A successful partnership between medtech companies and contract manufacturing organizations can help OEMs get products to market faster, meet quality requirements, support Design for Manufacturability, and reduce costs and inventories.
CereVasc raised $43.9 million in series A financing to support the development of a minimally invasive alternative for hydrocephalus, a condition sometimes called "water on the brain."
A recent survey suggests that dentists should engage with patients on social media to share educational content, but that doesn't mean patients want to see images from bloody procedures in their newsfeeds.
Like many of its peers, including Boston Scientific and Johnson & Johnson, Medtronic's business has been impacted by procedure deferrals as healthcare systems around the world have deferred most elective surgery to focus on COVID-19.
The $4.7 million loan under the paycheck protection program comes after the Billerica, MA-based company furloughed about one-third of its workforce because of sharp declines in procedures.
The robotic surgery pioneer beat Wall Street estimates and saw an increase in revenue before COVID-19 cases began to rise in the United States.
As more medical device companies update 2020 guidance, the business impact of COVID-19 becomes somewhat clearer.